Medical Research
Work Instability Linked to Fatigue, Depression in Ankylosing Spondylitis

Work Instability Linked to Fatigue, Depression in Ankylosing Spondylitis
Increased risk of Atrial Fibrillation in Certain Ankylosing Spondylitis Patients

Increased risk of Atrial Fibrillation in Certain Ankylosing Spondylitis Patients
Ankylosing Spondylitis Is Associated with Risk of New Onset Obstructive Sleep Apnea: A Nationwide Population-Based Cohort Study

Ankylosing Spondylitis Is Associated with Risk of New Onset Obstructive Sleep Apnea: A Nationwide Population-Based Cohort Study
Cannabis Laws Lessen the Opioid Crisis

Cannabis Laws Lessen the Opioid Crisis
Three reports from JAMA Internal Medicine demonstrate favorable trends with less opioid use when cannabis became legal.
Simponi Lowers Incidence of Acute Anterior Uveitis, Phase 4 Study Shows

Simponi Lowers Incidence of Acute Anterior Uveitis, Phase 4 Study Shows
Treatment with Simponi (golimumab) reduced the incidence of a type of eye inflammation called acute anterior uveitis (AAU) and decreased disease activity in patients with ankylosing spondylitis (AS), according to a Phase 4 clinical study in a real-world setting.
Why Biosimilars Can Never Be Identical To Originators–and Why They Don’t Need To Be
Why Biosimilars Can Never Be Identical To Originators–and Why They Don’t Need To Be
They are ‘living’ molecules, and there is variability among lots, even in the reference products. The key issue is whether the variability has any clinical significance. So far, it hasn’t.
Ankylosing spondylitis prevalence doubled from 2006 to 2016
Ankylosing spondylitis prevalence doubled from 2006 to 2016
EULAR: MMR, Herpes Zoster Vaccines Permitted With Immunosuppressive Therapies
EULAR: MMR, Herpes Zoster Vaccines Permitted With Immunosuppressive Therapies
EULAR recommendations now state that vaccines for measles, mumps and rubella, as well as herpes zoster, may be considered with caution in adult patients with autoimmune inflammatory rheumatic diseases at risk, according to a 2019 update published in the Annals of the Rheumatic Diseases.
Ixekizumab superior to adalimumab for joint, skin improvement in PsA

Ixekizumab superior to adalimumab for joint, skin improvement in PsA
Ixekizumab is superior to adalimumab in simultaneously improving both joint and skin disease in patients with psoriatic arthritis who have had an inadequate response to conventional synthetic DMARDs, according to data published in the Annals of the Rheumatic Diseases.
One-Third of Psoriatic Arthritis Patients Will Need Joint Surgery

One-Third of Psoriatic Arthritis Patients Will Need Joint Surgery
Dannish study has shown that one-third of psoriatic arthritis (PsA) will have joint surgery that that PsA patients have twice the rate of joint surgery when compared with the general population.
MRI Activity Scores & SpA

MRI Activity Scores & SpA
Intercorrelation between MRI disease activity scores of the sacroiliac joints and the spine, and clinical disease activity indices in patients with axial spondyloarthritis
Prevalence of spondyloarthritis and peripheral arthritis among patients IBD
Prevalence of spondyloarthritis and peripheral arthritis among patients IBD
Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease